BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8910514)

  • 1. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region.
    Ishida T; Mizushima Si; Azuma S; Kobayashi N; Tojo T; Suzuki K; Aizawa S; Watanabe T; Mosialos G; Kieff E; Yamamoto T; Inoue J
    J Biol Chem; 1996 Nov; 271(46):28745-8. PubMed ID: 8910514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling.
    Ishida TK; Tojo T; Aoki T; Kobayashi N; Ohishi T; Watanabe T; Yamamoto T; Inoue J
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9437-42. PubMed ID: 8790348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
    Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
    J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40.
    Tsukamoto N; Kobayashi N; Azuma S; Yamamoto T; Inoue J
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1234-9. PubMed ID: 9990007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
    Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
    Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation.
    Pype S; Declercq W; Ibrahimi A; Michiels C; Van Rietschoten JG; Dewulf N; de Boer M; Vandenabeele P; Huylebroeck D; Remacle JE
    J Biol Chem; 2000 Jun; 275(24):18586-93. PubMed ID: 10764746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway.
    Kashiwada M; Shirakata Y; Inoue JI; Nakano H; Okazaki K; Okumura K; Yamamoto T; Nagaoka H; Takemori T
    J Exp Med; 1998 Jan; 187(2):237-44. PubMed ID: 9432981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor.
    Nakano H; Oshima H; Chung W; Williams-Abbott L; Ware CF; Yagita H; Okumura K
    J Biol Chem; 1996 Jun; 271(25):14661-4. PubMed ID: 8663299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation.
    Aizawa S; Nakano H; Ishida T; Horie R; Nagai M; Ito K; Yagita H; Okumura K; Inoue J; Watanabe T
    J Biol Chem; 1997 Jan; 272(4):2042-5. PubMed ID: 8999898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.
    Pullen SS; Dang TT; Crute JJ; Kehry MR
    J Biol Chem; 1999 May; 274(20):14246-54. PubMed ID: 10318845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent.
    Manning E; Pullen SS; Souza DJ; Kehry M; Noelle RJ
    Eur J Immunol; 2002 Jan; 32(1):39-49. PubMed ID: 11754002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel RING finger protein interacts with the cytoplasmic domain of CD40.
    Hu HM; O'Rourke K; Boguski MS; Dixit VM
    J Biol Chem; 1994 Dec; 269(48):30069-72. PubMed ID: 7527023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.
    Wong BR; Josien R; Lee SY; Vologodskaia M; Steinman RM; Choi Y
    J Biol Chem; 1998 Oct; 273(43):28355-9. PubMed ID: 9774460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).
    Arcipowski KM; Stunz LL; Graham JP; Kraus ZJ; Vanden Bush TJ; Bishop GA
    J Biol Chem; 2011 Mar; 286(12):9948-55. PubMed ID: 21262968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression.
    Miller WE; Cheshire JL; Raab-Traub N
    Mol Cell Biol; 1998 May; 18(5):2835-44. PubMed ID: 9566902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.
    Darnay BG; Ni J; Moore PA; Aggarwal BB
    J Biol Chem; 1999 Mar; 274(12):7724-31. PubMed ID: 10075662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling.
    Rowland SL; Tremblay MM; Ellison JM; Stunz LL; Bishop GA; Hostager BS
    J Immunol; 2007 Oct; 179(7):4645-53. PubMed ID: 17878362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel zinc finger protein that inhibits osteoclastogenesis and the function of tumor necrosis factor receptor-associated factor 6.
    Shin JN; Kim I; Lee JS; Koh GY; Lee ZH; Kim HH
    J Biol Chem; 2002 Mar; 277(10):8346-53. PubMed ID: 11751921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.
    Miller WE; Mosialos G; Kieff E; Raab-Traub N
    J Virol; 1997 Jan; 71(1):586-94. PubMed ID: 8985387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.